Esther Arnaiz

813 total citations
9 papers, 537 citations indexed

About

Esther Arnaiz is a scholar working on Cancer Research, Molecular Biology and Immunology. According to data from OpenAlex, Esther Arnaiz has authored 9 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Esther Arnaiz's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Esther Arnaiz is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Esther Arnaiz collaborates with scholars based in United Kingdom, Spain and Switzerland. Esther Arnaiz's co-authors include Carla Solé, Charles H. Lawrie, Lorea Manterola, David Otaegui, Leire Iparraguirre, Adrian L. Harris, James A. Nathan, Brian M. Ortmann, Patrick H. Maxwell and Ana Peñalver and has published in prestigious journals such as Nature Communications, Nature Genetics and Frontiers in Immunology.

In The Last Decade

Esther Arnaiz

9 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Arnaiz United Kingdom 7 481 440 33 32 27 9 537
Shuai Fang China 10 512 1.1× 491 1.1× 37 1.1× 20 0.6× 39 1.4× 26 633
Ting Shuang China 10 286 0.6× 252 0.6× 31 0.9× 17 0.5× 38 1.4× 15 380
Erika Larrea Spain 6 283 0.6× 259 0.6× 25 0.8× 18 0.6× 34 1.3× 8 362
Kouichi Kinoshita Japan 4 493 1.0× 407 0.9× 27 0.8× 16 0.5× 60 2.2× 5 567
Chenglai Dong China 7 401 0.8× 260 0.6× 51 1.5× 17 0.5× 79 2.9× 10 482
Reyhaneh Ravanbakhsh Gavgani Iran 11 234 0.5× 172 0.4× 20 0.6× 18 0.6× 63 2.3× 26 305
Jiangnan Qiu China 9 286 0.6× 218 0.5× 20 0.6× 13 0.4× 36 1.3× 13 359

Countries citing papers authored by Esther Arnaiz

Since Specialization
Citations

This map shows the geographic impact of Esther Arnaiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Arnaiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Arnaiz more than expected).

Fields of papers citing papers by Esther Arnaiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Arnaiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Arnaiz. The network helps show where Esther Arnaiz may publish in the future.

Co-authorship network of co-authors of Esther Arnaiz

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Arnaiz. A scholar is included among the top collaborators of Esther Arnaiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Arnaiz. Esther Arnaiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Arnaiz, Esther, Brian M. Ortmann, James A. West, et al.. (2023). A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesis. Nature Communications. 14(1). 4816–4816. 14 indexed citations
2.
Arnaiz, Esther & Adrian L. Harris. (2022). Role of Hypoxia in the Interferon Response. Frontiers in Immunology. 13. 821816–821816. 14 indexed citations
3.
Arnaiz, Esther, Ana Miar, Antônio Gregorio Dias, et al.. (2021). Hypoxia Regulates Endogenous Double-Stranded RNA Production via Reduced Mitochondrial DNA Transcription. Frontiers in Oncology. 11. 779739–779739. 16 indexed citations
4.
Arnaiz, Esther, Ana Miar, Esther Bridges, et al.. (2021). Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs. BMC Cancer. 21(1). 896–896. 5 indexed citations
5.
Ortmann, Brian M., Natalie Burrows, Ian Lobb, et al.. (2021). The HIF complex recruits the histone methyltransferase SET1B to activate specific hypoxia-inducible genes. Nature Genetics. 53(7). 1022–1035. 45 indexed citations
6.
Solé, Carla, Esther Arnaiz, Lorea Manterola, David Otaegui, & Charles H. Lawrie. (2019). The circulating transcriptome as a source of cancer liquid biopsy biomarkers. Seminars in Cancer Biology. 58. 100–108. 96 indexed citations
7.
Solé, Carla, Esther Arnaiz, & Charles H. Lawrie. (2018). MicroRNAs as Biomarkers of B-cell Lymphoma. Biomarker Insights. 13. 4203104056–4203104056. 29 indexed citations
8.
Arnaiz, Esther, Ibai Goicoechea, Iñigo Prada-Luengo, et al.. (2018). PO-471 Circular RNA detection in melanoma patients’ plasma. ESMO Open. 3. A415–A415. 1 indexed citations
9.
Arnaiz, Esther, Carla Solé, Lorea Manterola, et al.. (2018). CircRNAs and cancer: Biomarkers and master regulators. Seminars in Cancer Biology. 58. 90–99. 317 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026